Title

ASCO Coronavirus Resources

As the nation continues to respond to the coronavirus (COVID-19) pandemic, ASCO is committed to providing the most current information and resources to its members and the larger oncology community to help ensure that individuals with cancer receive high-quality care.

ASCO has compiled a wide range of resources to support clinicians, the cancer care delivery team, and patients with cancer. Please continue to check back for the most current information. We are united in working together to continue the critical work of conquering cancer during this health care crisis.

ASCO and Conquer Cancer would like to thank the below donors for generously funding The COVID Impacts Cancer Fund.

Amgen
AstraZeneca
Bayer HealthCare Pharmaceuticals Inc.
BeiGene
Blueprint Medicines
Boehringer Ingelheim Pharmaceuticals, Inc.
Bristol Myers Squibb
Daiichi Sankyo, Inc.
Deciphera Pharmaceuticals, LLC
EMD Serono Inc.
Epizyme
Exelixis, Inc.
GlaxoSmithKline
Genentech BioOncology TM
Gilead Sciences, Inc.
HELSINN
Incyte Corporation
Janssen Pharmaceutical Companies of Johnson & Johnson
Lilly
Melanoma Research Foundation
Merck & Co., Inc.
Natera, Inc.
Nebraska Oncology Society
Novartis Oncology
Novocure
Pfizer Oncology
Sanofi Genzyme
SeaGen Inc.
​TAIHO Oncology, Inc.
Takeda Oncology

Random Quote

"ASCO is leading the move to a new data-driven era of discovery in clinical oncology."
Peter Paul Yu, MD, FACP, FASCO
ASCO President, 2014-15